EUVIMEDEUVIMED entdecken
Klinische Studie (Phase II)Open Access · CC BY-NC-ND 4.0

Long-term Clinical Outcome of Trastuzumab and Lapatinib for HER2-positive Metastatic Colorectal Cancer

Federica Tosi, Andrea Sartore-Bianchi, Sara Lonardi, Alessio Amatu, Francesco Leone, Silvia Ghezzi, Cosimo Martino, Katia Bencardino, Erica Bonazzina, Francesca Bergamo, Elisabetta Fenocchio, Erika Martinelli und 17 weitere

Clinical Colorectal Cancer · 2020-12 · 19 (4) · 256-262.e2

DOI: 10.1016/j.clcc.2020.06.009 ↗

Kurz gefasst

Klinische Studie (Phase II) in der Zeitschrift Clinical Colorectal Cancer, 2020-12. Verfasst von Federica Tosi und 28 weiteren Autor:innen. Beteiligte Einrichtung: Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy; Dipartimento di Oncologia ed Emato-Oncologia, Università degli Studi di…. Die Arbeit wurde bisher 82-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Associazione Italiana per la Ricerca sul Cancro, Pfizer, Fondazione Regionale per la Ricerca Biomedica.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdultAgedAged, 80 and overAntibodies, Monoclonal, HumanizedAntineoplastic Combined Chemotherapy ProtocolsBiomarkers, TumorBrainBrain NeoplasmsColorectal NeoplasmsFemaleFollow-Up StudiesHumansImmunohistochemistryLapatinibMagnetic Resonance ImagingMaleMiddle AgedProgression-Free SurvivalProto-Oncogene Proteins p21(ras)Erb-b2 Receptor Tyrosine Kinases

Stichwörter der Autor:innen

CNS metastasesColorectal cancerHER2LapatinibTrastuzumab

Substanzen

Antibodies, Monoclonal, HumanizedBiomarkers, TumorLapatinibProto-Oncogene Proteins p21(ras)Erb-b2 Receptor Tyrosine KinasesTrastuzumabKRAS protein, humanERBB2 protein, humanpertuzumab

Autor:innen und Institutionen

  • Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy; Dipartimento di Oncologia ed Emato-Oncologia, Università degli Studi di Milano, Milan, Italy.
  • Oncologia Medica 1, Istituto Oncologico Veneto - IRCCS, Padova, Italy.
  • Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy.
  • Department of Oncology, ASL BI, Ospedale degli Infermi, Biella, Italy; Istituto di Candiolo, Fondazione del Piemonte per l'Oncologia-IRCCS, Candiolo, Italy.
  • Istituto di Candiolo, Fondazione del Piemonte per l'Oncologia-IRCCS, Candiolo, Italy.
  • Multidisciplinary Outpatient Oncology Clinic, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Turin, Italy.

Förderung

  • Associazione Italiana per la Ricerca sul Cancro
  • Pfizer
  • Fondazione Regionale per la Ricerca Biomedica
  • European Society for Medical Oncology
  • Bayer
  • Horizon 2020
  • Sanofi
  • Fondazione Europea Ricerca Biomedica

Zitieren

APA

Tosi, F., Sartore-Bianchi, A., Lonardi, S., Amatu, A., Leone, F., Ghezzi, S., Martino, C., Bencardino, K., Bonazzina, E., Bergamo, F., Fenocchio, E., Martinelli, E., Troiani, T., Siravegna, G., Mauri, G., Torri, V., Marrapese, G., Valtorta, E., Cassingena, A., …, & Siena, S. (2020). Long-term Clinical Outcome of Trastuzumab and Lapatinib for HER2-positive Metastatic Colorectal Cancer. Clinical Colorectal Cancer, 19(4), 256-262.e2. https://doi.org/10.1016/j.clcc.2020.06.009

Vancouver

Tosi F, Sartore-Bianchi A, Lonardi S, Amatu A, Leone F, Ghezzi S, et al. Long-term Clinical Outcome of Trastuzumab and Lapatinib for HER2-positive Metastatic Colorectal Cancer. Clinical Colorectal Cancer. 2020;19(4):256-262.e2. doi:10.1016/j.clcc.2020.06.009

BibTeX
@article{Tosi2020,
  author = {Tosi, Federica and Sartore-Bianchi, Andrea and Lonardi, Sara and Amatu, Alessio and Leone, Francesco and Ghezzi, Silvia and Martino, Cosimo and Bencardino, Katia and Bonazzina, Erica and Bergamo, Francesca and Fenocchio, Elisabetta and Martinelli, Erika and Troiani, Teresa and Siravegna, Giulia and Mauri, Gianluca and Torri, Valter and Marrapese, Giovanna and Valtorta, Emanuele and Cassingena, Andrea and Cappello, Giovanni and Bonoldi, Emanuela and Vanzulli, Angelo and Regge, Daniele and Ciardiello, Fortunato and Zagonel, Vittorina and Bardelli, Alberto and Trusolino, Livio and Marsoni, Silvia and Siena, Salvatore},
  title = {Long-term Clinical Outcome of Trastuzumab and Lapatinib for HER2-positive Metastatic Colorectal Cancer},
  journal = {Clinical Colorectal Cancer},
  year = {2020},
  volume = {19},
  number = {4},
  pages = {256--262.e2},
  doi = {10.1016/j.clcc.2020.06.009}
}
Kostenlos starten →